LUCD 8-K SEC Filing Analysis

Latest settled — T+20d ⚠ clustered

LUCD ▲ +4.72% at T+20d

NEUTRAL call ✓ call won +4.72% · α vs SPY -0.24% · entry $1.06 → $1.11

Next anchor: T+60d in 5w

Last close $0.9610 (close Jun 12) · -9.34% from $1.06 entry

Entry anchored
Apr 24, 03:59 PM ET
via Databento tick

T+1d

-1.89%

call -1.89% · α -1.40%

$1.04

settled 7w ago

T+5d

+2.83%

call +2.83% · α +2.43%

$1.09

settled 6w ago

T+20d

+4.72%

call +4.72% · α -0.24%

$1.11

settled 24d ago

T+60d

—

call — · α —

—

in 5w

Price Chart

Loading chart...

Executive Summary

Lucid Diagnostics Inc. (LUCD) closed an underwritten public offering of 18 million shares at $1.00 per share, raising $18 million in gross proceeds and approximately $16.8 million in net proceeds. The company plans to use the funds for working capital and general corporate purposes.

Actionable Insight

Monitor upcoming financial reports for how the company allocates the new capital and whether it improves operational metrics. The dilution from issuing 18 million new shares may pressure the stock price despite the cash infusion.

Key Facts

Closed an underwritten offering of 18,000,000 shares at $1.00 per share
Gross proceeds of $18 million, net proceeds of approximately $16.8 million
Proceeds to be used for working capital and general corporate purposes
Offering was anchored by a $15 million investment from a fundamental institutional investor
Canaccord Genuity LLC and BTIG, LLC acted as joint bookrunners

Financial Impact

Raises $16.8 million in net proceeds through issuance of 18 million shares, representing significant dilution to existing shareholders

dilutioncashequity

Risk Factors

Significant shareholder dilution from issuing 18 million new shares
No specific strategic use of funds disclosed beyond general working capital needs
Execution risk in deploying capital effectively to improve business performance

Market Snapshot

Exchange

Nasdaq

Sector

Surgical & Medical Instruments & Apparatus

Analyst Consensus

91% bullish (11 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

Document	Accession Number
8-K Filing (Primary)	0001493152-26-018926
Exhibit: ex99-1.htm	0001493152-26-018926
Document: 0001493152-26-018926-index-headers.html	0001493152-26-018926
Document: 0001493152-26-018926-index.html	0001493152-26-018926
Document: 0001493152-26-018926.txt	0001493152-26-018926

3 reports for LUCD

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for LUCD — sortable, filterable
	Type				Now
May 14, 2026 4w ago	8-K BEARISH ★ 5/10	$1.02 $1.00	▲ +1.96%	▲ +1.24%	$0.9610 (+5.78%)
Apr 24, 2026 7w ago	8-K NEUTRAL ★ 5/10	$1.06 $1.09	▲ +2.83%	▲ +2.43%	$0.9610 (−9.34%)
Apr 23, 2026 7w ago	8-K NEUTRAL ★ 5/10	$1.07 $1.07	· 0.00%	▼ −0.91%	$0.9610 (−10.19%)

US Market Status

Market Closed — Opens in 4h 9m

Related Tickers

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access